Comparative efficacy and safety between amisulpride and olanzapine in schizophrenia treatment and a cost analysis in China: a systematic review, meta-analysis, and cost-minimization analysis

Peer Review reports

Original Submission
15 Jan 2018	Submitted	Original manuscript
26 Feb 2018	Reviewed	Reviewer Report - Vesta Steibliene
2 Mar 2018	Reviewed	Reviewer Report - Markos Tesfaye
8 Mar 2018	Reviewed	Reviewer Report - Xiufeng Xu
11 Jun 2018	Author responded	Author comments - Peng Men
Resubmission - Version 2
11 Jun 2018	Submitted	Manuscript version 2
8 Jul 2018	Reviewed	Reviewer Report - Markos Tesfaye
8 Jul 2018	Reviewed	Reviewer Report - Vesta Steibliene
14 Jul 2018	Reviewed	Reviewer Report - Xiufeng Xu
24 Aug 2018	Author responded	Author comments - Peng Men
Resubmission - Version 3
24 Aug 2018	Submitted	Manuscript version 3
Publishing
28 Aug 2018	Editorially accepted
5 Sep 2018	Article published	10.1186/s12888-018-1867-8

Back to article page